Respiratory Syncytial Virus

This study presents a review of the treatment and prevention strategies for respiratory syncytial virus. Respiratory syncytial virus (RSV) is a common cause of severe lower respiratory tract disease globally, especially in young children. Despite its high prevalence and morbidity, the available therapy is mostly supportive. Recent developments in novel therapies offer hope for reducing...

This study provides a review of the transmission, pathophysiology, and clinical manifestation of respiratory syncytial virus infection. Respiratory syncytial virus (RSV) is a common respiratory pathogen with a bimodal distribution, mostly affecting the pediatric and geriatric populations. Affected healthy adults are usually asymptomatic, but severe infection can occur in elderly, immunocompromised, or other high-risk populations....

This study presents a review of new antibody-based therapies for respiratory syncytial virus and a revised list of the most promising candidates based on the results of the latest clinical trials. The human respiratory syncytial virus (hRSV) causes seasonal outbreaks and can result in severe outcomes for high-risk populations such as preterm children and older...

Respiratory syncytial virus prefusion F candidate vaccine is safe and can boost humoral and cell-mediated immune responses in older adults. Respiratory syncytial virus (RSV) causes respiratory tract infections with seasonal peaks. Natural immunity is incomplete and short-lived. Severe RSV-associated lower respiratory tract disease (RSV-LRTD) occurs in older adults (mostly ≥60 years), especially with underlying medical...

CDC expected to meet later in the month to adopt vaccine recommendations for older Americans. Older adults have a second vaccine option for respiratory syncytial virus (RSV) following the U.S. Food and Drug Administration approval of a Pfizer vaccine on Wednesday. The other shot for adults 60 years and older is made by GlaxoSmithKline. It...

Learning about asthma remission and management strategies can help you gain control of your condition and maintain better long-term health. As with any chronic medical disease, it is vital to understand its causes, treatments, and associated self-care procedures.  Asthma symptoms can negatively impact your daily life. But, it can go into remission with proper management...

Key Takeaways An RSV vaccine from Pfizer is effective in protecting seniors and newborns, clinical trial data show. The vaccine is 86% effective in protecting older adults and 82% effective in protecting newborns whose mothers received the jab. The vaccine could be approved for use in older adults and expecting mothers by this summer. The...